Abstract
Background and Objectives The goals of depression screening, which is universally recommended in primary care settings in the U.S., are to identify adolescents with depression and connect them to treatment. However, little is known about how depression screening affects the likelihood of being diagnosed with a mental disorder or accessing mental health care over time.
Methods This longitudinal cohort study used insurance claims data from 57,732 adolescents who had at least one routine well-visit between 2014 and 2017. Using propensity score matching, we compared adolescents who were screened for depression to similar adolescents who were not screened for depression during the well-visit. Diagnostic and treatment-related outcomes were examined over 6-month follow-up and included depression diagnoses, mood-related diagnoses, antidepressant prescriptions, any mental health-related prescriptions, and psychotherapy. We also examined heterogeneity of associations by sex.
Results Compared to adolescents who were not screened for depression, adolescents screened for depression were 30% more likely to be diagnosed with depression (RR=1.30, 95% CI=1.11-1.52) and 17% more likely to receive a mood-related diagnosis (RR=1.17, 95% CI=1.08-1.27), but were not more likely to be treated with an antidepressant prescription (RR=1.11, 95% CI=0.82-1.51), any mental health prescription (RR=1.15, 95% CI=0.87-1.53), or psychotherapy (RR=1.13, 95% CI=0.98-1.31). In general, associations were stronger among females.
Conclusions Adolescents who were screened for depression during a well-visit were more likely to receive a diagnosis of depression or a mood-related disorder in the six months following screening. Future research should explore methods for increasing access to treatment and treatment uptake following screening.
Clinical Trial Registration (if any) N/A
Table of Contents Summary Insurance claims data were used to explore associations between depression screening during routine well-visits and depression diagnoses, psychiatric prescriptions, and psychotherapy among adolescents.
What’s Known on This Subject Depression screening is increasingly viewed as a key strategy for addressing depression among adolescents. To inform clinical guidelines, the United States Preventive Services Task Force has called for research to examine the diagnostic and treatment-related outcomes of depression screening.
What This Study Adds In a sample of 57,732 adolescents, adolescents who were screened for depression during a well-visit were more likely to receive a depression or mood-related diagnosis over 6-month follow-up, but were not more likely to be treated with medication or psychotherapy.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Funding Statement
Ms. Riehm was supported by a Ruth L. Kirschstein National Research Service Award from the National Institute of Mental Health (1F31MH124330-01) and by a Doctoral Foreign Study Award from the Canadian Institutes of Health Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed by the Johns Hopkins Institutional Review Board and was determined to be human subjects research that meets criteria for exemption under category four (i.e., secondary analysis of existing, de-identified data).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest Disclosures (includes financial disclosures): The authors have no conflicts of interest relevant to this article to disclose.
Funding/Support: Ms. Riehm was supported by a Ruth L. Kirschstein National Research Service Award from the National Institute of Mental Health (1F31MH124330-01) and by a Doctoral Foreign Study Award from the Canadian Institutes of Health Research.
Role of Funder/Sponsor (if any): The National Institute of Mental Health and the Canadian Institutes of Health Research had no role in the design and conduct of this study.
Contributors’ Statement Page Ms. Riehm conceptualized and designed the study, cleaned and analyzed the data, drafted the initial manuscript, and reviewed and revised the manuscript.
Dr. Brignone assembled the dataset and reviewed the manuscript.
Dr. Stuart, Dr. Gallo, and Dr. Mojtabai assisted in designing the analytic approach, interpreting results, and reviewing the manuscript.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Data Availability
These data are covered under a Data Use Agreement between the Johns Hopkins Bloomberg School of Public Health and Highmark Health.
Abbreviations
- (BCBS)
- Blue Cross Blue Shield
- (CPT)
- Current Procedural Terminology
- (HCPCS)
- Healthcare Common Procedure Coding System
- (ICD)
- International Classification of Diseases
- (RCT)
- Randomized controlled trial
- (US)
- Relative risk (RR); United States
- (USPSTF)
- United States Preventive Services Task Force
